Compounds > tobramycin
Page last updated: 2024-08-23

tobramycin and carbapenems

tobramycin has been researched along with carbapenems in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19901 (5.00)18.7374
1990's0 (0.00)18.2507
2000's2 (10.00)29.6817
2010's9 (45.00)24.3611
2020's8 (40.00)2.80

Authors

AuthorsStudies
Livermore, DM; Said, AA1
Ariza, J; Ayats, J; Borraz, C; Cabellos, C; Corbella, X; Doménech, A; Gudiol, F; Montero, A; Tubau, F1
Cleveland, KO; Gelfand, MS; Mazumder, SA1
Cacciarelli, TV; Muder, RR; Shields, RK; Singh, N; Sun, HY1
Anan, N; Ito, A; Nakamura, R; Toba, S; Tsuji, M1
Kemper, AL; Young, DC; Zobell, JT1
Fusté, E; Gainza, E; López-Jiménez, L; Segura, C; Viñas, M; Vinuesa, T1
Mataraci-Kara, E; Ozbek Celik, B; Yilmaz, M1
Adibhesami, H; Aliramezani, A; Boroumand, MA; Douraghi, M; Ghourchian, S; Jasemi, S; Mohammadzadeh, M; Rahbar, M; Zeraati, H1
Aboklaish, AF; Böttger, EC; Cao, S; Crich, D; Ercan, O; Hobbie, SN; Hughes, D; Huseby, DL; Juhas, M; Petersson, A; Polikanov, YS; Rominski, A; Teo, J; Tyrrell, JM; Walsh, TR; Widlake, E1
Avery, LM; Nicolau, DP; Sutherland, CA1
Ammeter, D; Arthur, G; Idowu, T; Schweizer, F; Zhanel, GG1
Burgess, DS; Clark, JA; Kulengowski, B1
Becker, K; Gysin, M; Haldimann, K; Hobbie, SN; Plattner, M1
Friberg, LE1
Ali, HB; Asuman, B; Kubra, HU; Sarah, AF; Sreylis, N; Yeliz, TC1
Bragantini, D; Carrara, E; Cattaneo, P; Chiamenti, M; Ellis, S; Franceschi, F; Giske, CG; Lodise, T; Menchinelli, G; Piddock, LJV; Righi, E; Sanguinetti, M; Savoldi, A; Scudeller, L; Tacconelli, E1
Chen, L; Du, H; Fouts, DE; Hao, M; Kreiswirth, BN; Satlin, M; Schuyler, J; Shashkina, E; Zhang, H1
Ashley, EA; Becker, K; Gysin, M; Haldimann, K; Hinfonthong, P; Hobbie, SN; Hon, PY; Hopkins, J; Kaewphanderm, N; Kesteman, T; Ling, CL; Nguyen, TH; Pham, TD; Roberts, T; Sengduangphachanh, A; Simmalavong, M; Simpson, AJH; Tan, P; Tran, HH; Turner, P; van Doorn, HR; Vasoo, S1
Huang, Y; Liu, H; Lu, W; Peng, J; Qin, G; Wu, D; Xiao, J1

Reviews

1 review(s) available for tobramycin and carbapenems

ArticleYear
Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli.
    International journal of antimicrobial agents, 2021, Volume: 57, Issue:5

    Topics: Amikacin; Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Cephalosporins; Colistin; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; In Vitro Techniques; Microbial Sensitivity Tests; Polymyxins; Rifampin; Tazobactam; Tobramycin

2021

Other Studies

19 other study(ies) available for tobramycin and carbapenems

ArticleYear
In-vitro interactions of FCE 22101 with aminoglycosides against gram-negative rods.
    The Journal of antimicrobial chemotherapy, 1989, Volume: 23 Suppl C

    Topics: Amikacin; Anti-Bacterial Agents; Carbapenems; Drug Interactions; Gentamicins; Gram-Negative Bacteria; Lactams; Microbial Sensitivity Tests; Tobramycin

1989
Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 54, Issue:6

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rifampin; Tobramycin

2004
Successful treatment with doripenem and tobramycin of ventriculitis due to imipenem- and meropenem-resistant Pseudomonas aeruginosa.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 63, Issue:6

    Topics: Adult; Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Resistance, Bacterial; Encephalitis; Humans; Imipenem; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin

2009
A novel combination regimen for the treatment of refractory bacteremia due to multidrug-resistant Pseudomonas aeruginosa in a liver transplant recipient.
    Transplant infectious disease : an official journal of the Transplantation Society, 2010, Volume: 12, Issue:6

    Topics: Anti-Bacterial Agents; Bacteremia; Bile Duct Diseases; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Liver Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome

2010
[In vitro combination effects of doripenem with aminoglycoside or ciprofloxacin against Pseudomonas aeruginosa].
    The Japanese journal of antibiotics, 2011, Volume: 64, Issue:4

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Ciprofloxacin; Doripenem; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin

2011
The use of doripenem in pediatric cystic fibrosis patients in case of meropenem shortages.
    Pediatric pulmonology, 2014, Volume: 49, Issue:3

    Topics: Adolescent; Anti-Bacterial Agents; Burkholderia cenocepacia; Burkholderia Infections; Carbapenems; Child; Cystic Fibrosis; Disease Progression; Doripenem; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Pseudomonas stutzeri; Rhodospirillaceae; Thienamycins; Tobramycin; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination

2014
Carbapenem-resistance mechanisms of multidrug-resistant Pseudomonas aeruginosa.
    Journal of medical microbiology, 2013, Volume: 62, Issue:Pt 9

    Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; Base Sequence; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Dipeptides; Drug Resistance, Multiple, Bacterial; Drug Synergism; Membrane Transport Proteins; Meropenem; Microbial Sensitivity Tests; Molecular Sequence Data; Porins; Pseudomonas aeruginosa; Thienamycins; Tobramycin

2013
Effects of various antibiotics alone or in combination with doripenem against Klebsiella pneumoniae strains isolated in an intensive care unit.
    BioMed research international, 2014, Volume: 2014

    Topics: Carbapenems; Colistin; Doripenem; Dose-Response Relationship, Drug; Drug Combinations; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Minocycline; Rifampin; Tigecycline; Tobramycin

2014
Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period.
    Letters in applied microbiology, 2016, Volume: 63, Issue:6

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Iran; Microbial Sensitivity Tests; Minocycline; Sulbactam; Tigecycline; Tobramycin

2016
In vitro activity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumannii.
    The Journal of antimicrobial chemotherapy, 2019, 04-01, Volume: 74, Issue:4

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Africa; Aminoglycosides; Anti-Bacterial Agents; Asia; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Genotype; Humans; Microbial Sensitivity Tests; Nebramycin; South America; Whole Genome Sequencing

2019
Prevalence of in vitro synergistic antibiotic interaction between fosfomycin and nonsusceptible antimicrobials in carbapenem-resistant Pseudomonas aeruginosa.
    Journal of medical microbiology, 2019, Volume: 68, Issue:6

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Fosfomycin; Humans; Meropenem; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Tobramycin; United States

2019
Potentiation of β-lactam antibiotics and β-lactam/β-lactamase inhibitor combinations against MDR and XDR Pseudomonas aeruginosa using non-ribosomal tobramycin-cyclam conjugates.
    The Journal of antimicrobial chemotherapy, 2019, 09-01, Volume: 74, Issue:9

    Topics: Adjuvants, Pharmaceutic; Animals; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Carbapenems; Ceftazidime; Drug Combinations; Erythrocytes; HEK293 Cells; Heterocyclic Compounds; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Swine; Tobramycin

2019
In vitro activity of plazomicin compared to other clinically relevant aminoglycosides in carbapenem-resistant Enterobacteriaceae.
    Diagnostic microbiology and infectious disease, 2020, Volume: 98, Issue:2

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Multiple, Bacterial; Gentamicins; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sisomicin; Tobramycin

2020
Epidemiologic, Phenotypic, and Structural Characterization of Aminoglycoside-Resistance Gene
    International journal of molecular sciences, 2020, Aug-25, Volume: 21, Issue:17

    Topics: Acetyltransferases; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Catalytic Domain; Databases, Genetic; Drug Resistance, Bacterial; Genome, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Methyltransferases; Molecular Epidemiology; Mutagenesis, Site-Directed; Nebramycin; Standard of Care; Structure-Activity Relationship

2020
Pivotal Role of Translation in Anti-Infective Development.
    Clinical pharmacology and therapeutics, 2021, Volume: 109, Issue:4

    Topics: Aminoglycosides; Anti-Infective Agents; Antiviral Agents; Carbapenems; Dose-Response Relationship, Drug; Drug Approval; Drug Development; Drug Discovery; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Models, Biological; Nebramycin; Research Design; United States; United States Food and Drug Administration

2021
Investigation of isepamicin in vitro efficiency in Gram negative bacteria efficacy of isepamicin.
    Indian journal of medical microbiology, 2021, Volume: 39, Issue:1

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Gentamicins; Gram-Negative Bacteria; Microbial Sensitivity Tests; Netilmicin; Pseudomonas aeruginosa; Tobramycin

2021
Apramycin resistance in epidemic carbapenem-resistant Klebsiella pneumoniae ST258 strains.
    The Journal of antimicrobial chemotherapy, 2021, 07-15, Volume: 76, Issue:8

    Topics: Anti-Bacterial Agents; Carbapenems; Epidemics; Humans; Klebsiella Infections; Klebsiella pneumoniae; Multilocus Sequence Typing; Nebramycin

2021
Apramycin susceptibility of multidrug-resistant Gram-negative blood culture isolates in five countries in Southeast Asia.
    International journal of antimicrobial agents, 2022, Volume: 60, Issue:4

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Asia, Southeastern; Blood Culture; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Gentamicins; Gram-Negative Bacteria; Microbial Sensitivity Tests; Nebramycin; Pseudomonas aeruginosa; Tobramycin

2022
The impact of multi-drug resistant Pseudomonas aeruginosa infections on acute pancreatitis patients.
    BMC infectious diseases, 2023, May-22, Volume: 23, Issue:1

    Topics: Acute Disease; Amikacin; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Drug Resistance, Multiple, Bacterial; Gentamicins; Humans; Microbial Sensitivity Tests; Pancreatitis; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Tobramycin

2023